Anti-very late antigen-1 monoclonal antibody modulates the development of secondary lesion and T-cell response in experimental arthritis.
(Q42617968)
scientific article published on January 2000
scientific article published on January 2000
Language:
Current Data About
Anti-very late antigen-1 monoclonal antibody modulates the development of secondary lesion and T-cell response in experimental arthritis.